The head of Ozempic maker Novo Nordisk A/S is among business executives who are meeting the Danish prime minister to discuss ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Capital Investment Advisors LLC increased its stake in shares of Novo Nordisk A/S (NYSE:NVO – Free Report) by 12.1% during ...

Short NVO slightly under 91.41, target n/a, stop loss @ 91.67 Check the time stamp on this data. Updated AI-Generated Signals ...

Calorie labels in supermarkets and restaurants have little impact on consumer choices, researchers found, fueling doubts ...

DKK 320 million has been awarded for the development of a new campus that will provide the setting for close collaboration ...

Europe’s aging population drives automation, with robots enhancing productivity, but high costs and challenges remain.

Novo Nordisk's shares plummeted due to disappointing trial results for CagriSema, with patients achieving only 22.7% weight ...

When President-elect Donald Trump recently floated the idea of annexing Canada, a key reason he gave was a claim that the ...

AdvisorNet Financial Inc trimmed its holdings in shares of The Kroger Co. (NYSE:KR – Free Report) by 4.4% in the fourth ...